Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
looks good today for a push in the 2's
indeed it is bro ! get ready for pennyland
0.0062 x0.0063 ! new highs day :)$$%%%
looking good ~
0.005x0.0058 ~ gappa
nice!
SHMN is ready for penny move this time
SHMN 0.005 great day
SHMN 0.0045 is building momo again ~
NTRR.0048 nice News out >>Neutra Focused on Growth
KATY, TX / ACCESSWIRE / February 4, 2021 / Neutra Corp. (OTC PINK:NTRR) ("Neutra" or "the Company") has decided to release a statement that management does not plan on having a share consolidation, also known as a "reverse split" at this time. Instead, the Company will focus on the growth of its wholly owned subsidiary VIVIS CBD.
"We have made leaps and bounds to where we were before in 2018," said Neutra CEO Sydney Jim. "We have built our own production facility, launched new CBD products, hired a national sales staff, and gained new white label contracts. Neutra will be concentrating on growing VIVIS CBD in the best interest of the Company and its shareholders. Hopefully, we will have our final piece for complete vertical integration soon."
About two weeks ago, Neutra released press on finding a cultivation site to complete its quest for vertical integration in the hemp-based CBD space. VIVIS hopes to be able to solidify the site soon and begin cultivating test crop for the cultivation side of the business.
About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.
NTRR.0048 nice News out >>Neutra Focused on Growth
KATY, TX / ACCESSWIRE / February 4, 2021 / Neutra Corp. (OTC PINK:NTRR) ("Neutra" or "the Company") has decided to release a statement that management does not plan on having a share consolidation, also known as a "reverse split" at this time. Instead, the Company will focus on the growth of its wholly owned subsidiary VIVIS CBD.
"We have made leaps and bounds to where we were before in 2018," said Neutra CEO Sydney Jim. "We have built our own production facility, launched new CBD products, hired a national sales staff, and gained new white label contracts. Neutra will be concentrating on growing VIVIS CBD in the best interest of the Company and its shareholders. Hopefully, we will have our final piece for complete vertical integration soon."
About two weeks ago, Neutra released press on finding a cultivation site to complete its quest for vertical integration in the hemp-based CBD space. VIVIS hopes to be able to solidify the site soon and begin cultivating test crop for the cultivation side of the business.
About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.
good morning ~
good morning ~
KITL is moving on thin air
hello bud
just watching it now Whale!
These results are timely, as we are seeing the emergence of new variants less responsive to first generation vaccines, thus making potential cross-reactivity another important advantage of next-generation vaccines,” said Andrei Floroiu, Vaxart’s Chief Executive Officer.
that is a good move from them !on close watch now
and KITL chart has been trying to breakout ! KITL on watch
https://www.stockscores.com/charts/charts/?ticker=kitl
good Morning ~thanks !looks like AABB has some things going on and wants to communicate with the investment community !
looks good
gm ! great DD !
SHMN 0.0035x0.0039 pm ~
0.0035x0.0039 pm~
SOHM, Inc., Announces Initial Purchase Order for its new CBD product line.
01/27/2021 posted in Press Releases
Share
CHINO HILLS, CA—January 27, 2021 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today some of the developments with the company and their new product line purchase orders into the US OTC retail, prescription, contract manufacturing, and white label manufacturing and marketing space.
SOHM has received an initial purchase order from its B2B customer for its newly launched CBD Pain Relief Cream in a private label agreement.
This is just the beginning of launching its CBD line of products into major retail stores. SOHM’s customer will be distributing them to various chain stores throughout the United States.
This new purchase order comes from a current customer that has been purchasing products from SOHM since 2017.
Mr. Baron Night, the CEO, said, “SOHM is very pleased to have received this order from this customer that supplies retail and pharmacy networks all across the United States. This represents an annualized commitment once this order is executed and the product is on the shelf of retail stores.
Mr. Night continued saying that the company also anticipates another purchase order for one of its travel size Hand Sanitizer products from the same customer. SOHM’s spokesperson said once the CBD based product line and other product orders are in its pipeline, it will assure that SOHM achieves its target for higher revenue growth in 2021 compared to previous years.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as has strategic alliances with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
https://www.sohm.com/2021/01/27/sohm-inc-announces-initial-purchase-order-for-its-new-cbd-product-line/#.YBGo5BXysVQ.twitter
Anyway it's Going to be an interesting trading day on AAPL
He will enjoy this short lived drop!AAPL price will recover very fast tomorrow
Are you short here?
vaccines Rollout delays is one of the causes big boards stocks drop today
MRNA too
already 225 !!
very big news here ! new 52 weeks highs in already pm trading
expect a small dip at open from some profit takers and then boom to new highs
216 $ in pm $$$$%%%%
the close over the 50 ma is a great indicator of that !
SHMN 0.005 great tweet >>>heading to pennies
0.0015 up
ARST on close watch ! thanks for this valuable info
0.0049 ~
0.0008 one left >>pm vol
hehehe ;)
good morning ~SHMN 0.0043x0.0044 gappa